www.fdanews.com/articles/148985-teva-1-billion-market-depends-on-new-test-of-laquinimod
Teva $1 Billion Market Depends on New Test of Laquinimod
August 27, 2012
Teva Pharmaceutical is recruiting about 1,800 patients for a new trial of its multiple sclerosis pill in a bid to improve how the disease is treated and secure a successor to its best-selling medicine.
Businessweek
Businessweek